Discovery of potent and selective reversible Bruton’s tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Discovery of potent and selective reversible Bruton’s tyrosine kinase inhibitors

Published:2021-06 Issue: Volume:40 Page:116163
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Qiu Hui^ORCID,Ali Zahid,Bender Andrew,Caldwell Richard,Chen Yi-Ying,Fang Zhizhou,Gardberg Anna^ORCID,Glaser Nina,Goettsche Anja,Goutopoulos Andreas,Grenningloh Roland,Hanschke Bettina^ORCID,Head Jared,Johnson Theresa^ORCID,Jones Christopher^ORCID,Jones Reinaldo,Kulkarni Shashank,Maurer Christine,Morandi Federica,Neagu Constantin,Poetzsch Sven,Potnick Justin,Schmidt Ralf,Roe Katherine,Viacava Follis Ariele,Wing Carolyn,Zhu Xiaohua,Sherer Brian

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference42 articles.

1. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia;Byrd;N Engl J Med,2014

2. Tec kinases: a family with multiple roles in immunity;Yang;Immunity,2000

3. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase;Khan;Immunol Res,2001

4. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies;Puri;Int Rev Immunol,2013

5. Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders;Robak;Expert Opin Investig Drugs,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recyclization of 5-Aryl-1H-pyrrole-2,3-diones with Amidoximes. Synthesis of Enamines Containing a 1,2,4-Oxadiazole Fragment;Russian Journal of Organic Chemistry;2024-03

2. Constructing Innovative Covalent and Noncovalent Compound Libraries: Insights from 3D Protein–Ligand Interactions;Journal of Chemical Information and Modeling;2024-02-21

3. Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure–activity relationship;Bioorganic Chemistry;2023-09

4. Machine learning-based classification models for non-covalent Bruton’s tyrosine kinase inhibitors: predictive ability and interpretability;Molecular Diversity;2023-07-21

5. Machine Learning-Based Classification Models for Non-Covalent Bruton's Tyrosine Kinase Inhibitors: Predictive Ability and Interpretability;2023-05-11